Amoxicillin

  • TRADE NAMES: A-Gram; Acimox; Almodan; Amodex; Amoxil (GSK); Apo-Amoxi; Augmentin (GSK); Clamoxyl; Clavulin (GSK); Eupen; Fisamox; Lin-Amnox; Novamoxin; Nu-Amoxi; Prevpac (TAP); Pro-Amox; Trimox (Bristol-Myers Squibb)
  • INDICATIONS: Infections of the respiratory tract, skin and urinary tract
  • SYNONYM: amoxycillin
  • CLASS: Antibiotic, penicillin
  • HALF-LIFE: 0.7–1.4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Allopurinol, Bromelain, Chloramphenicol, Demeclocycline, Doxycycline, Erythromycin, Imipenem/Cilastatin, Methotrexate, Minocycline, Omeprazole, Oxytetracycline, Sulfonamides, Tetracycline

PREGNANCY CATEGORY: B

Augmentin and Clavulin are trade names for a combination of amoxicillin and clavulanic acid. The International Nonproprietary Name for this combination is amoxicillin/clavulanic acid, and co-amoxiclav the British Approved Name.

Our database has 91 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
RENAL
RESPIRATORY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of amoxicillin in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 12/02/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top